Hengrui Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HENGRUI PHARMA, and what generic and branded alternatives to HENGRUI PHARMA drugs are available?
HENGRUI PHARMA has seventeen approved drugs.
Summary for Hengrui Pharma
| US Patents: | 0 |
| Tradenames: | 15 |
| Ingredients: | 14 |
| NDAs: | 17 |
Drugs and US Patents for Hengrui Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hengrui Pharma | IODIXANOL | iodixanol | INJECTABLE;INJECTION | 214271-001 | May 19, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hengrui Pharma | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 207252-001 | Aug 9, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hengrui Pharma | DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 209065-001 | Sep 19, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
